Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A-101 in common warts
NCT03210337Phase 2Completed
- Sponsor
- Aclaris Therapeutics, Inc.
- Start
- Aug 2017
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hydrogen peroxide gel in common warts, sponsored by Aclaris Therapeutics, Inc.. Started Aug 2017; status: completed.
02
Drugs
hydrogen peroxide gel
03
Conditions
common warts
Beyond the preview
Go deeper on NCT03210337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03210337.